[Ivacaftor (cystic fibrosis, 6 years and older, with G551D mutation) - Addendum to Commission A19-65]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003647
German
Original Title:
Ivacaftor (zystische Fibrose, ab 6 Jahre, mit G551D-Mutation) - Addendum zum Auftrag A19-65
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a20-04.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/A20-04_Ivacaftor_Addendum-zum-Auftrag-A19-65_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Cystic Fibrosis
- Child
- Adult
- Adolescent
- Drug Therapy
- Chloride Channel Agonists
- Quinolones
Keywords
- Ivacaftor
- Cystic Fibrosis
- Child
- Adolescent
- Adult
- Benefit Assessment
- NCT00909532
- NCT00909727
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.